|1.||Shibutani, Makoto: 7 articles (08/2014 - 05/2009)|
|2.||Mitsumori, Kunitoshi: 7 articles (10/2013 - 02/2009)|
|3.||Takahashi, Miwa: 5 articles (01/2015 - 05/2009)|
|4.||Inoue, Kaoru: 4 articles (01/2015 - 10/2011)|
|5.||Yoshida, Midori: 4 articles (01/2015 - 10/2011)|
|6.||Kawai, Masaomi: 4 articles (10/2013 - 02/2009)|
|7.||Nemoto, Kiyomitsu: 4 articles (02/2013 - 10/2011)|
|8.||Degawa, Masakuni: 4 articles (02/2013 - 10/2011)|
|9.||Corbel, Vincent: 3 articles (01/2013 - 01/2011)|
|10.||Ozawa, Shogo: 3 articles (01/2013 - 10/2011)|
01/01/2013 - "The epidemiological models, implemented in OpenMalaria, were employed to study the impact of a single mass distribution of LLINs on malaria, both in terms of episodes prevented during the effective lifetime of the batch of LLINs, and in terms of net health benefits (NHB) expressed in disability-adjusted life years (DALYs) averted during that period, depending on net type (standard pyrethroid-only LLIN or pyrethroid-piperonyl butoxide combination LLIN), resistance status, coverage and pre-intervention transmission level. "
01/01/2013 - "Efficacy of Olyset® Plus, a new long-lasting insecticidal net incorporating permethrin and piperonyl-butoxide against multi-resistant malaria vectors [corrected]."
01/01/2011 - "A process-explicit simulation of malaria transmission was applied to results of 4 recent Phase II experimental hut trials comparing a new mosaic long-lasting insecticidal net (LLIN) which combines deltamethrin and piperonyl butoxide with another LLIN product by the same manufacturer relying on deltamethrin alone. "
12/01/2014 - "The aim of this study was to measure the protective efficacy of Olyset(®) Plus, a new long-lasting factory-treated insecticidal net (LLIN) incorporated with 2% permethrin and 1% of the synergist piperonyl butoxide (PBO), against cutaneous leishmaniasis (CL) transmission under field conditions. "
06/01/2001 - "We report here infection with pubic lice in a 43 year old male in Australia which failed to be eradicated by adequate therapy with a pyrethrin and piperonyl butoxide product. "
03/01/2010 - "Following an increase in numbers and West Nile virus (WNV) infection rates of Culex tarsalis and Culex pipiens, the District decided on July 26, 2007, to conduct aerial applications of Evergreen EC 60-6 (60% pyrethrins: 6% piperonyl butoxide) over approximately 215 km2 in the north area of Sacramento County on the nights of July 30, July 31, and August 1, 2007. "
02/28/2010 - "Recognizing that wild birds confront toxicological stressors in the context of various physiological states, we exposed four groups (n=9-11) of 9-week-old chickens (Gallus domesticus) to drinking water with either SR (three alternate days at 50 microg/l resmethrin+150 microg/l piperonyl butoxide), CORT (10 days at 20mg/l to induce subacute stress), the combination of SR and CORT, or 0.10% ethanol vehicle coincident with WNV infection. "
11/01/1998 - "Increased liver weight, centrilobular hepatocellular hypertrophy due to increased smooth endoplasmic reticulum, decreased numbers and areas of connexin 32-positive spots per hepatocyte, and increased cell proliferation were observed in rats treated with 0.2 and 2% piperonyl butoxide. "
01/01/2013 - "In this study, we investigated CAR involvement in liver hypertrophy and hepatocarcinogenesis of Cyp2b-inducing nongenotoxic hepatocarcinogens, piperonyl butoxide (PBO), and decabromodiphenyl ether (DBDE), using wild-type and CAR knockout (CARKO) male mice. "
01/01/2015 - "Dose-dependent difference of nuclear receptors involved in murine liver hypertrophy by piperonyl butoxide."
01/01/2015 - "To clarify the involvement of constitutive androstane receptor (CAR) and other nuclear receptors in mouse liver hypertrophy induced by different doses of piperonyl butoxide (PBO), wild-type and CAR-knockout mice were administered PBO (200, 1,000, or 5,000 ppm) in the basal diet for 1 week. "
01/01/2013 - "Different pathways of constitutive androstane receptor-mediated liver hypertrophy and hepatocarcinogenesis in mice treated with piperonyl butoxide or decabromodiphenyl ether."
|2.||Cytochrome P-450 Enzyme System (Cytochrome P450)
|3.||cyclic adenosine-5'-trimetaphosphate (ATMP)
|7.||Parathion (Ethyl Parathion)
|9.||Tea Tree Oil
|10.||Androgen Receptors (Androgen Receptor)